The cutaneous inflammatory response is regulated by an intricate web of genetic control mechanisms, and specific inflammatory pathways appear to be dysfunctional in AD patients including inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2)-related pathways. The gene discussed is PTGS2; the disease is Alzheimer disease.